Chimerix Appoints Ronald C. Renaud, Jr. to Board of Directors By: Benzinga via Benzinga December 17, 2014 at 16:31 PM EST Chimerix, Inc. (Nasdaq: CMRX), a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, today ... Read More >> Related Stocks: Chimerix Inc